Live tape
Top 8, mentions 7d17,495MSFT3,302 mentions▲ +0.08GOOGL2,678 mentions▲ +0.05AAPL2,282 mentions▲ +0.07META2,224 mentions▲ +0.04SPCX1,992 mentions▲ +0.06SNDK1,840 mentions▲ +0.06NVDA1,751 mentions▲ +0.07QQQ1,426 mentions▲ +0.04

Equity · Healthcare

GRAL

GRAIL, Inc. · NasdaqGS

$73.00 +1.39% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart Chart by TradingView
Track this symbol on TradingView

The chart above plots the price of GRAL over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 54 sessions over that window: $54.00 on 1 May 2026 through $73.00 on 17 July 2026. Finazon · prior-day close.

Market cap $3.1B
52-week range $31.41 – $116.00
Avg volume 91.6K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Jul 29, 2026

GRAL insider trades

SEC Form 4 · last 90 days · newest reported trade 15 Jul 2026
Open-market buys 0
Open-market sells 1
Net sold $91K
Non-trade filings 9
Date Insider Type Shares Value
04 Jun 2026 Partridge Andrew John Chief Growth Officer Sell 1,491 $91K
Compensation mechanics (9 filings)

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
15 Jul 2026 CHASE WILLIAM J Director Award 276 $21K
15 Jul 2026 MIZELL STEVEN Director Award 268 $20K
15 Jul 2026 SUMME GREGORY L Director Award 427 $32K
18 Jun 2026 CHASE WILLIAM J Director Award 5,491 $350K
18 Jun 2026 Krevans Sarah Director Award 5,491 $350K
18 Jun 2026 SUMME GREGORY L Director Award 5,491 $350K
18 Jun 2026 MIZELL STEVEN Director Award 5,491 $350K
03 Jun 2026 Ofman Joshua J. Chief Executive Officer Award 3,154 $193K
01 Jun 2026 Ofman Joshua J. Chief Executive Officer Award 27,901 $1.80M

GRAL reported financials

SEC EDGAR XBRL

GRAL reported revenue of $147.2M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$408.4M.

Figure Reported Period
Revenue $147.2M 31 Dec 2025 fiscal year
Net income −$408.4M 31 Dec 2025 fiscal year
Diluted EPS −$11.11 31 Dec 2025 fiscal year
Total assets $2.8B 31 Mar 2026 at period end
Total equity $2.5B 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

GRAL earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $-2.29 $41M
31 Dec 2025 FY 2025 $-11.11 $147M
30 Sep 2025 Q3 2025 $-2.46 $36M
30 Jun 2025 Q2 2025 $-3.18 $36M

Reported figures & scheduled dates · SEC EDGAR filings

GRAL institutional holders

SEC Form 13F

11 of the 45 institutional funds we track reported a GRAL position for the quarter ended 31 Mar 2026 — a combined $247.1M; the latest of those filings landed 15 May 2026.

Fund Action Shares Value
Baker Bros. Advisors Added +93.2% shares 4,028,614 $208.2M
AQR Capital Management Held (±25%) −10.7% shares 292,004 $14.6M
D. E. Shaw & Co. Added +102.6% shares 81,606 $4.2M
GAMCO Investors Added +170.7% shares 66,758 $3.5M
Two Sigma Investments Trimmed −36.2% shares 64,687 $3.3M
Marshall Wace Added +196.5% shares 59,900 $3.1M
Renaissance Technologies Trimmed −35.3% shares 55,200 $2.9M
Man Group Added +235.5% shares 51,073 $2.6M
Citadel Advisors Trimmed −49.7% shares 33,894 $1.8M
Tudor Investment Corp Held (±25%) +10.6% shares 31,465 $1.6M

Source: SEC EDGAR 13F filings

GRAL fails-to-deliver

SEC CNS data

On 29 Jun 2026, 177,005 shares of GRAL failed to deliver (about $11.7M).

Settlement date Shares failed Notional % of shares out
29 Jun 2026 177,005 $11.7M 0.412%
25 Jun 2026 182 $12K <0.001%
24 Jun 2026 458 $28K 0.001%
22 Jun 2026 2,000 $127K 0.005%
18 Jun 2026 187 $11K <0.001%
17 Jun 2026 152 $9K <0.001%
16 Jun 2026 37,860 $2.3M 0.088%
15 Jun 2026 2,170 $130K 0.005%

Source: SEC fails-to-deliver (CNS) data